Urinary epidermal growth factor/monocyte chemotactic peptide 1 ratio as non-invasive predictor of Mayo clinic imaging classes in autosomal dominant polycystic kidney disease

BACKGROUND: Age- and height-adjusted total kidney volume is currently considered the best prognosticator in patients with autosomal dominant polycystic kidney disease. We tested the ratio of urinary epidermal growth factor and monocyte chemotactic peptide 1 for the prediction of the Mayo Clinic Imag...

Descripción completa

Detalles Bibliográficos
Autores principales: Rocchetti, Maria Teresa, Pesce, Francesco, Matino, Silvia, Piscopo, Giovanni, di Bari, Ighli, Trepiccione, Francesco, Capolongo, Giovanna, Perniola, Maria Antonietta, Song, Xuewen, Khowaja, Saima, Haghighi, Amirreza, Peters, Dorien, Paolicelli, Simona, Pontrelli, Paola, Netti, Giuseppe Stefano, Ranieri, Elena, Capasso, Giovambattista, Moschetta, Marco, Pei, York, Gesualdo, Loreto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10227134/
https://www.ncbi.nlm.nih.gov/pubmed/36342644
http://dx.doi.org/10.1007/s40620-022-01468-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10227134/
https://www.ncbi.nlm.nih.gov/pubmed/36342644
http://dx.doi.org/10.1007/s40620-022-01468-w

Ejemplares similares